Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Denis Migliorini

Showing results (1-10 of 71) with videos related to

Pageof 8
Sort By:
Neuro-Oncology|October 11, 2025
CAR T cell therapy for meningioma: mesothelin emerges as a novel promising targetDenis Migliorini
Praxis|March 1, 2023
An Overview of Cytokine Release Syndrome and Other Side Effects of CAR-T Cell TherapyVassilis Genoud, Denis Migliorini
International Journal of Molecular Sciences|April 3, 2021
Challenging Hurdles of Current Targeting in Glioblastoma: A Focus on Immunotherapeutic StrategiesVassilis Genoud, Denis Migliorini
Frontiers in Neurology|March 27, 2023
Novel pathophysiological insights into CAR-T cell associated neurotoxicityVassilis Genoud, Denis Migliorini
Iscience|February 12, 2026
CAR-T cell therapies are coming after glioblastoma: An overview of early phase clinical trials and future perspectivesAnnapaola Mariniello, Denis Migliorini
Neuro-Oncology|July 25, 2015
The CD40/CD40L axis in glioma progression and therapyPaul R Walker, Denis Migliorini
Revue Medicale Suisse|June 11, 2016
[Immunotherapy for brain tumors: obstacles and perspectives]Denis Migliorini, Pierre-Yves Dietrich
Biomedicines|August 26, 2022
CAR T-Based Therapies in Lymphoma: A Review of Current Practice and PerspectivesSemira Sheikh, Denis Migliorini, Noémie Lang
International Journal of Molecular Sciences|October 14, 2020
Oncolytic Viruses as a Platform for the Treatment of Malignant Brain TumorsJana de Sostoa, Valérie Dutoit, Denis Migliorini
Current Opinion in Oncology|August 13, 2019
Current strategies for vaccination in glioblastomaValérie Dutoit, Denis Migliorini, Pierre-Yves Dietrich
Pageof 8

Showing results (1-10 of 71) with videos related to

Sort By:
Pageof 8
Neuro-Oncology|October 11, 2025
CAR T cell therapy for meningioma: mesothelin emerges as a novel promising targetDenis Migliorini
Praxis|March 1, 2023
An Overview of Cytokine Release Syndrome and Other Side Effects of CAR-T Cell TherapyVassilis Genoud, Denis Migliorini
International Journal of Molecular Sciences|April 3, 2021
Challenging Hurdles of Current Targeting in Glioblastoma: A Focus on Immunotherapeutic StrategiesVassilis Genoud, Denis Migliorini
Frontiers in Neurology|March 27, 2023
Novel pathophysiological insights into CAR-T cell associated neurotoxicityVassilis Genoud, Denis Migliorini
Iscience|February 12, 2026
CAR-T cell therapies are coming after glioblastoma: An overview of early phase clinical trials and future perspectivesAnnapaola Mariniello, Denis Migliorini
Neuro-Oncology|July 25, 2015
The CD40/CD40L axis in glioma progression and therapyPaul R Walker, Denis Migliorini
Revue Medicale Suisse|June 11, 2016
[Immunotherapy for brain tumors: obstacles and perspectives]Denis Migliorini, Pierre-Yves Dietrich
Biomedicines|August 26, 2022
CAR T-Based Therapies in Lymphoma: A Review of Current Practice and PerspectivesSemira Sheikh, Denis Migliorini, Noémie Lang
International Journal of Molecular Sciences|October 14, 2020
Oncolytic Viruses as a Platform for the Treatment of Malignant Brain TumorsJana de Sostoa, Valérie Dutoit, Denis Migliorini
Current Opinion in Oncology|August 13, 2019
Current strategies for vaccination in glioblastomaValérie Dutoit, Denis Migliorini, Pierre-Yves Dietrich
Pageof 8